Purpose
to develop a safe and effective CMV/HIV vaccine that will fully exploit the early vulnerability of HIV infection to potent effector-memory T cell responses, and will be suitable for clinical translation
Grantee
Division
Global Health
Date
SEPTEMBER 2011
Region served
GLOBAL
Committed amount
$7,958,944
Grant topic
HIV
Duration (months)
46
Grantee location
Portland, Oregon, United States
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.